Faes Farma SA - Company Profile
Powered by
All the data and insights you need on Faes Farma SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Faes Farma SA Strategy Report
- Understand Faes Farma SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Faes Farma SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
20 Sep 2021 | Hikma Pharma Enters into Licensing Agreement with Faes Farma for Commercialization of Bilastine in US | Licensing Agreement |
Hikma Pharmaceuticals Plc
|
Faes Farma SA |
09 Mar 2021 | Faes Farma to Acquire Global Farma | Acquisition |
Faes Farma SA
|
Global Farma, SA
|
23 Dec 2020 | Faes Farma SA Enters Phase II/III Clinical Trial Agreement with Scope International AG for calcifediol (GDCT0408410) | Contract Service Agreement |
Faes Farma SA
|
Scope International AG
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer